May 28, 2019
InBios Receives FDA Market Authorization for its ZIKV Detect 2.0 IgM Capture ELISA for a Presumptive Diagnosis of Zika Virus Infection
By info@inbios.com|2023-10-25T20:03:53+00:00May 28th, 2019|InBios In the News|
InBios Receives FDA Market Authorization for its ZIKV Detect 2.0 IgM Capture ELISA for a Presumptive Diagnosis of Zika Virus Infection
By info@inbios.com|2023-10-25T20:04:14+00:00May 23rd, 2019|InBios In the News|
FDA Grants Marketing Authorization for First Diagnostic Test for Detecting Zika IgM Antibodies to InBios
By info@inbios.com|2023-10-25T20:04:55+00:00January 4th, 2019|Conferences|
ASM Biothreats, January 29-31, 2019, Arlington, VA, Booth 26
By info@inbios.com|2023-10-25T20:05:30+00:00October 8th, 2018|InBios In the News|
InBios announces FDA clearance of its Dengue NS1 ELISA kit
By info@inbios.com|2023-10-25T20:06:17+00:00October 8th, 2018|Conferences|
ASTMH, October 28 - November 1, 2018, Sheraton new Orleans, New Orleans, LA Booth 424-426
By info@inbios.com|2023-10-25T20:06:48+00:00August 21st, 2017|Conferences|
APHL June 2 - 5, 2018, Pasadena Convention Center, Pasadena, CA
By info@inbios.com|2023-10-25T20:07:34+00:00August 21st, 2017|Conferences|
AACC July 31 - August 2, 2018, McCormick Place, Chicago, IL, Booth 540
By info@inbios.com|2023-10-25T20:08:21+00:00June 30th, 2017|Conferences|
Medica November 13 - November 16, 2017 - Düsseldorf, Germany, Hall 3, Booth 3D29-13
By info@inbios.com|2023-10-25T20:08:45+00:00December 20th, 2016|Conferences|
AACC July 30 - August 3, 2017 - San Diego Convention Center
By info@inbios.com|2023-10-25T20:09:26+00:00December 20th, 2016|Conferences|
APHL June 11 – 14, 2017 Rhode Island Convention Center